APA (7th ed.) Citation

Saxena, R., Chandra, V., Manohar, M., Hajela, K., Debnath, U., Prabhakar, Y. S., . . . Dwivedi, A. (2013). Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Saxena, Ruchi, et al. Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways. Public Library of Science (PLoS), 2013.

MLA (8th ed.) Citation

Saxena, Ruchi, et al. Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways. Public Library of Science (PLoS), 2013.